Strong Third Quarter Revenue and EBITDA
Third quarter revenue was $400 million and adjusted EBITDA was $95 million, both ahead of the guidance provided earlier.
Positive Enrollment Growth
New and total enrollment volumes increased 7% and 6%, respectively, compared to the third quarter of the prior year.
Stock Repurchase Program Expansion
The Board authorized a $150 million increase to the stock repurchase program, highlighting a disciplined approach to capital allocation.
Revenue Growth in Mexico and Peru
On a year-to-date basis, Mexico's revenue grew 8% and adjusted EBITDA increased 21%. Peru's revenue increased 7% with adjusted EBITDA up 5%, both adjusted for timing impacts.